Pharmacogenomic medicine in autism: challenges and opportunities

Paediatr Drugs. 2015 Apr;17(2):115-24. doi: 10.1007/s40272-014-0106-0. Bowers K1, Lin PI, Erickson C. Abstract Autism spectrum disorder (ASD) affects 1 in 68 children in the US and is distinguished by core deficits in social interactions. Developing pharmacologic treatments for ASD is complicated by clinical and genetic heterogeneity. Although pharmacological treatments have not been shown to be(…)